Furthermore, circulating tumor cells cultured from ER-positive/HER2-negative breast cancer patients revealed discrete HER2+ (proliferative) and HER2− (less proliferative, more drug-resistant) subpopulations that can interconvert spontaneously (58). The gene discussed is ERBB2; the disease is breast carcinoma.